Search

Robert M Kunemund

Examiner (ID: 4089)

Most Active Art Unit
1714
Art Unit(s)
1107, 1765, 1714, 1792, 1722, 1109, 1103, 1763
Total Applications
3442
Issued Applications
2671
Pending Applications
149
Abandoned Applications
593

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 12030818 [patent_doc_number] => 20170320917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-09 [patent_title] => 'Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway' [patent_app_type] => utility [patent_app_number] => 15/628771 [patent_app_country] => US [patent_app_date] => 2017-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22668 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15628771 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/628771
Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway Jun 20, 2017 Abandoned
Array ( [id] => 14169143 [patent_doc_number] => 10258557 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-16 [patent_title] => Peptide for stimulating melanogenesis [patent_app_type] => utility [patent_app_number] => 15/626891 [patent_app_country] => US [patent_app_date] => 2017-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 2287 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15626891 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/626891
Peptide for stimulating melanogenesis Jun 18, 2017 Issued
Array ( [id] => 14088061 [patent_doc_number] => 10239924 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-03-26 [patent_title] => Peptide having eight amino acid sequences derived from cage and retaining anticancer activity and activity to promote anticancer drug sensitivity of anticancer drug-resistant cancer cells [patent_app_type] => utility [patent_app_number] => 15/624906 [patent_app_country] => US [patent_app_date] => 2017-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 4084 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15624906 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/624906
Peptide having eight amino acid sequences derived from cage and retaining anticancer activity and activity to promote anticancer drug sensitivity of anticancer drug-resistant cancer cells Jun 15, 2017 Issued
Array ( [id] => 14652687 [patent_doc_number] => 20190233472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-01 [patent_title] => NOVEL TRIPEPTIDE [patent_app_type] => utility [patent_app_number] => 16/309641 [patent_app_country] => US [patent_app_date] => 2017-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3731 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16309641 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/309641
Tripeptides having angiotensin converting enzyme inhibitory activity and uses thereof Jun 15, 2017 Issued
Array ( [id] => 15267423 [patent_doc_number] => 20190382445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-19 [patent_title] => PEPTIDE HAVING MELANOGENESIS-INHIBITING ACTIVITY AND COMPOSITION COMPRISING SAME [patent_app_type] => utility [patent_app_number] => 16/308410 [patent_app_country] => US [patent_app_date] => 2017-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4139 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308410 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/308410
PEPTIDE HAVING MELANOGENESIS-INHIBITING ACTIVITY AND COMPOSITION COMPRISING SAME Jun 8, 2017 Abandoned
Array ( [id] => 11977587 [patent_doc_number] => 20170281742 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-05 [patent_title] => 'H3.3 CTL Peptides and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 15/613837 [patent_app_country] => US [patent_app_date] => 2017-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 18660 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15613837 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/613837
H3.3 CTL peptides and uses thereof Jun 4, 2017 Issued
Array ( [id] => 12092536 [patent_doc_number] => 20170349629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-07 [patent_title] => 'Angiotensin-1-Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 15/612763 [patent_app_country] => US [patent_app_date] => 2017-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10510 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15612763 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/612763
Angiotensin-1-receptor antagonists Jun 1, 2017 Issued
Array ( [id] => 11963569 [patent_doc_number] => 20170267722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-21 [patent_title] => 'INHIBITORY PEPTIDES OF VIRAL INFECTION' [patent_app_type] => utility [patent_app_number] => 15/605877 [patent_app_country] => US [patent_app_date] => 2017-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19647 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15605877 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/605877
Inhibitory peptides of viral infection May 24, 2017 Issued
Array ( [id] => 14497927 [patent_doc_number] => 20190192618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-27 [patent_title] => SPR741 HUMAN PHARMACOKINETICS AND EFFICACIOUS DOSE [patent_app_type] => utility [patent_app_number] => 16/301355 [patent_app_country] => US [patent_app_date] => 2017-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3910 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16301355 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/301355
SPR741 HUMAN PHARMACOKINETICS AND EFFICACIOUS DOSE May 14, 2017 Abandoned
Array ( [id] => 11992465 [patent_doc_number] => 20170296620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-19 [patent_title] => 'BIS-SULFHYDRYL MACROCYCLIZATION SYSTEMS' [patent_app_type] => utility [patent_app_number] => 15/592517 [patent_app_country] => US [patent_app_date] => 2017-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 18962 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15592517 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/592517
Bis-sulfhydryl macrocyclization systems May 10, 2017 Issued
Array ( [id] => 16304158 [patent_doc_number] => 10772929 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-09-15 [patent_title] => Use of peptide compounds in treating acute pancreatitis [patent_app_type] => utility [patent_app_number] => 16/094881 [patent_app_country] => US [patent_app_date] => 2017-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 6349 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 192 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16094881 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/094881
Use of peptide compounds in treating acute pancreatitis May 10, 2017 Issued
Array ( [id] => 14581289 [patent_doc_number] => 20190218253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-18 [patent_title] => Therapeutic SALL4 Peptide [patent_app_type] => utility [patent_app_number] => 16/095603 [patent_app_country] => US [patent_app_date] => 2017-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14566 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095603 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/095603
Therapeutic spalt-like transcription factor 4 (SALL4) peptide Apr 27, 2017 Issued
Array ( [id] => 16498886 [patent_doc_number] => 10864253 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-12-15 [patent_title] => Tissue protective peptides for preventing and treating diseases and disorders associated with tissue damage [patent_app_type] => utility [patent_app_number] => 16/096247 [patent_app_country] => US [patent_app_date] => 2017-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 29982 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16096247 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/096247
Tissue protective peptides for preventing and treating diseases and disorders associated with tissue damage Apr 27, 2017 Issued
Array ( [id] => 16105391 [patent_doc_number] => 10695279 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-30 [patent_title] => Peptide having skin-whitening activity and use thereof [patent_app_type] => utility [patent_app_number] => 15/554067 [patent_app_country] => US [patent_app_date] => 2017-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 5747 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15554067 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/554067
Peptide having skin-whitening activity and use thereof Apr 26, 2017 Issued
Array ( [id] => 11866159 [patent_doc_number] => 20170233445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-17 [patent_title] => 'ANTI-MICROBIAL PEPTIDE AND METHOD FOR TREATING MICROBIAL INFECTION' [patent_app_type] => utility [patent_app_number] => 15/498482 [patent_app_country] => US [patent_app_date] => 2017-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8416 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15498482 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/498482
Anti-microbial peptide and method for treating microbial infection Apr 26, 2017 Issued
Array ( [id] => 11979314 [patent_doc_number] => 20170283468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-05 [patent_title] => 'PEPTIDES FOR DIAGNOSIS AND TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 15/497851 [patent_app_country] => US [patent_app_date] => 2017-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 10346 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15497851 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/497851
Peptides for diagnosis and treatment of cancer Apr 25, 2017 Issued
Array ( [id] => 14868009 [patent_doc_number] => 20190284246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-19 [patent_title] => PEPTIDE INHIBITING COLONIZATION BY PATHOGENIC BACTERIA, AND COLONIZATION INHIBITOR INCLUDING SAME [patent_app_type] => utility [patent_app_number] => 16/097219 [patent_app_country] => US [patent_app_date] => 2017-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11648 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097219 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/097219
Peptide inhibiting colonization by pathogenic bacteria, and colonization inhibitor including same Apr 24, 2017 Issued
Array ( [id] => 11852044 [patent_doc_number] => 20170226537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-10 [patent_title] => 'ALCOHOL PRODUCT PROCESSES' [patent_app_type] => utility [patent_app_number] => 15/495027 [patent_app_country] => US [patent_app_date] => 2017-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13720 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15495027 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/495027
ALCOHOL PRODUCT PROCESSES Apr 23, 2017 Abandoned
Array ( [id] => 11993944 [patent_doc_number] => 20170298099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-19 [patent_title] => 'BIOLOGICALLY ACTIVE PEPTIDOMIMETIC MACROCYCLES' [patent_app_type] => utility [patent_app_number] => 15/493301 [patent_app_country] => US [patent_app_date] => 2017-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 36765 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15493301 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/493301
BIOLOGICALLY ACTIVE PEPTIDOMIMETIC MACROCYCLES Apr 20, 2017 Abandoned
Array ( [id] => 12001816 [patent_doc_number] => 20170305971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-26 [patent_title] => 'POTENT COMPSTATIN ANALOGS' [patent_app_type] => utility [patent_app_number] => 15/490437 [patent_app_country] => US [patent_app_date] => 2017-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14463 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15490437 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/490437
POTENT COMPSTATIN ANALOGS Apr 17, 2017 Abandoned
Menu